Sage Journals: Discover world-class research

Retricted access

Case report

First published 2022-7

Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two cases

Zheng Yan, Shuna Yao, Junhui Yuan [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2023-7

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

Andrew Walker, Alexandre Chan, Constanza Cortés Labra [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020-7

Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Yulin Wan, Shanshan An, Yanchao Zhou [...]

Cancer Control

Open access

Review article

First published 2022

Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma

David J Benjamin, Nataliya Mar, Arash Rezazadeh Kalebasty

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2024

Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy

Ali N. Kamali, Haleh Hamedifar, Michael Eisenhut [...]

Therapeutic Advances in Vaccines and Immunotherapy

Retricted access

Research article

First published 2022-3

The use of tacrolimus in the management of checkpoint inhibitor immunotherapy-induced hepatitis

Stuart McIlwaine, Anna Cullen, Leanne Stratton [...]

Journal of the Royal College of Physicians of Edinburgh

Open access

Case report

First published 2022

Review of Checkpoint Inhibitor Immunotherapy in Neuroendocrine Tumor of Prostate and Our Experience in 2 Cases

Akriti Pokhrel, Kiron Nair, Vijay Jaswani [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Research article

First published 2024-4

Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis

Alyssa N Nylander, William Rowles, Shane Poole [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2023

NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors

Yuanshuo A. Wang, Daniel Ranti, Christine Bieber [...]

Bladder Cancer

Open access

Case report

First published 2024

Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature

Maxime Rémond, Atanas Pachev, Maxime Battistella [...]

Therapeutic Advances in Medical Oncology

Search results